Assignee
CALGENT BIOTECHNOLOGY CO LTD
TW·5 granted patents·1 pending application·0 citations·filing 2016–2024
Top patents by PatentIndex Score
6 records- 0178US2024246915A1Aminonaphthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0275US12453708B2Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2023·Granted Oct 28, 2025·0 cites·9 claims
- 0367US11084786B2Compounds and pharmaceutical composition associated with ubiquitination-proteasome systemCALGENT BIOTECHNOLOGY CO LTD·Filed 2020·Granted Aug 10, 2021·0 cites·12 claims
- 0464US11919858B2Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2020·Granted Mar 5, 2024·0 cites·5 claims
- 0555US10745350B2Compounds and pharmaceutical composition associated with ubiquitination-proteasome systemCALGENT BIOTECHNOLOGY CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·17 claims
- 0647US11833122B2Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2016·Granted Dec 5, 2023·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when CALGENT BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →